Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11,181,416
-
Total 13F shares
-
30,097,815
-
Share change
-
-2,285,707
-
Total reported value
-
$42,738,427
-
Price per share
-
$1.42
-
Number of holders
-
56
-
Value change
-
-$4,456,204
-
Number of buys
-
26
-
Number of sells
-
25
Institutional Holders of ImageneBio, Inc. - Common Stock, $0.001 par value (IKNA) as of Q1 2024
As of 31 Mar 2024,
ImageneBio, Inc. - Common Stock, $0.001 par value (IKNA) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,097,815 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, BVF INC/IL, Blue Owl Capital Holdings LP, ORBIMED ADVISORS LLC, Omega Fund Management, LLC, BlackRock Inc., VANGUARD GROUP INC, Verition Fund Management LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.